Insula Centrum Badan Klinicznych Sp. z o.o. is an enterprise based in Poland. Its main office is in Warsaw. It operates in the Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) sector. Insula Centrum Badan Klinicznych Sp. z o.o. was incorporated on December 23, 2020. From the latest financial highlights, Insula Centrum Badan Klinicznych Sp. z o.o. reported a net sales revenue increase of 81.24% in 2023. Its’ total assets recorded a growth of 87.06%. The net profit margin of Insula Centrum Badan Klinicznych Sp. z o.o. decreased by 0.59% in 2023.
Headquarters
Ul. Klobucka 23C/109
Warsaw; Mazowieckie;
Postal Code: 02-699
Contact Details: Purchase the Insula Centrum Badan Klinicznych Sp. z o.o. report to view the information.
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service